Dr. Davis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1255 Graham Rd
Florissant, MO 63031Phone+1 314-820-6800Fax+1 314-820-6679- Is this information wrong?
Education & Training
- McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 2014 - 2017
- Northwestern University The Feinberg School of MedicineClass of 2014
Certifications & Licensure
- IL State Medical License 2014 - 2026
- MO State Medical License 2020 - 2025
- IA State Medical License 2014 - 2021
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 9 citationsGenomic Complexity Predicts Resistance to Endocrine Therapy and CDK4/6 Inhibition in Hormone Receptor-Positive (HR+)/HER2-Negative Metastatic Breast Cancer.Andrew A Davis, Jingqin Luo, Tiantian Zheng, Chao Dai, Xiaoxi Dong, Lu Tan, Rama Suresh, Foluso O Ademuyiwa, Caron Rigden, Timothy P Rearden, Katherine Clifton, Kather...> ;Clinical Cancer Research. 2023 May 1
- 4 citationsCirculating tumour DNA characterisation of invasive lobular carcinoma in patients with metastatic breast cancer.Andrew A Davis, Lorenzo Gerratana, Katherine Clifton, Arielle J Medford, Marko Velimirovic, Whitney L Hensing, Leslie Bucheit, Ami N Shah, Paolo D'Amico, Carolina Redu...> ;Ebiomedicine. 2022 Dec 1
- 3 citationsModeling the Prognostic Impact of Circulating Tumor Cells Enumeration in Metastatic Breast Cancer for Clinical Trial Design Simulation.Lorenzo Gerratana, Jean-Yves Pierga, James M Reuben, Andrew A Davis, Firas H Wehbe, Luc Dirix, Tanja Fehm, Franco Nolé, Rafael Gisbert-Criado, Dimitrios Mavroudis, Sal...> ;The Oncologist. 2022 Jul 5
- Join now to see all
Lectures
- A prospective study tracking longitudinal changes in genome-wide cell-free DNA (cfDNA) methylation to identify early nonresponders to cancer treatment.2019 ASCO Annual Meeting - 6/1/2019
- Whole-genome cell-free DNA (cfDNA) changes as a dynamic blood-based biomarker for early response assessment of advanced tumors.2019 ASCO Annual Meeting - 6/1/2019
Hospital Affiliations
- Siteman Cancer CenterSaint Louis, Missouri
- Barnes-Jewish HospitalSaint Louis, Missouri
- Christian HospitalSaint Louis, Missouri
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: